Statistics Powering Risk-Based Quality Management

CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical trial data with digital or remote tools (eCOA, ePRO, etc.) without placing the quality of that collected data at risk, in this DIA Global Annual Meeting 2023 interview.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Blog

ICH E6(R3), Demystified Part 4: Informed Consent

From Signature to System: Why E6(R3) Raises the Bar For years, informed consent has too often...

Blog

RBQM for the Mid-Market Explained

Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with...

Blog

5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires

Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a...